Significance of follow-up thoracic imaging in myasthenia gravis

Hiroyuki Murai, Yuriko Nagane, Shigeaki Suzuki, Tomihiro Imai, Masakatsu Motomura, Kimiaki Utsugisawa

Research output: Contribution to journalArticle

Abstract

Objectives: Most patients with myasthenia gravis (MG) undergo thoracic imaging at initial diagnosis. However, the follow-up protocol is unclear. The objective of the present study was to clarify the follow-up status and main findings of thoracic imaging in patients with MG. Methods: A total of 649 patients with disease duration ≥1 year were included in the study. The follow-up rate and time from the initial scan to the latest thoracic imaging were evaluated. The rate of abnormality and details of abnormal findings in both non-thymomatous MG and thymoma-associated MG were investigated. Results: The follow-up thoracic imaging rate of 145 patients with thymoma-associated MG was 71.7%, whereas just 46.2% of 504 patients with non-thymomatous MG underwent follow-up imaging. Abnormal findings were detected in 8.6% of patients with non-thymomatous MG and 26.0% of those with thymoma-associated MG. Abnormal findings included cancer, lung infection and lymph node swelling in the former, and relapse or increased size of thymoma in the latter. Conclusions: Frequent follow up by thoracic imaging is necessary in patients with MG.

Original languageEnglish
Pages (from-to)246-250
Number of pages5
JournalClinical and Experimental Neuroimmunology
Volume9
Issue number4
DOIs
Publication statusPublished - 2018 Nov 1

Fingerprint

Myasthenia Gravis
Thorax
Thymoma
Lung Neoplasms
Lymph Nodes
Recurrence
Infection

Keywords

  • cancer
  • myasthenia gravis
  • thoracic imaging
  • thymoma

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Immunology
  • Immunology and Microbiology (miscellaneous)
  • Clinical Neurology

Cite this

Significance of follow-up thoracic imaging in myasthenia gravis. / Murai, Hiroyuki; Nagane, Yuriko; Suzuki, Shigeaki; Imai, Tomihiro; Motomura, Masakatsu; Utsugisawa, Kimiaki.

In: Clinical and Experimental Neuroimmunology, Vol. 9, No. 4, 01.11.2018, p. 246-250.

Research output: Contribution to journalArticle

Murai, Hiroyuki ; Nagane, Yuriko ; Suzuki, Shigeaki ; Imai, Tomihiro ; Motomura, Masakatsu ; Utsugisawa, Kimiaki. / Significance of follow-up thoracic imaging in myasthenia gravis. In: Clinical and Experimental Neuroimmunology. 2018 ; Vol. 9, No. 4. pp. 246-250.
@article{da7e2a0881d14c79bdb1190c4f8d3fe9,
title = "Significance of follow-up thoracic imaging in myasthenia gravis",
abstract = "Objectives: Most patients with myasthenia gravis (MG) undergo thoracic imaging at initial diagnosis. However, the follow-up protocol is unclear. The objective of the present study was to clarify the follow-up status and main findings of thoracic imaging in patients with MG. Methods: A total of 649 patients with disease duration ≥1 year were included in the study. The follow-up rate and time from the initial scan to the latest thoracic imaging were evaluated. The rate of abnormality and details of abnormal findings in both non-thymomatous MG and thymoma-associated MG were investigated. Results: The follow-up thoracic imaging rate of 145 patients with thymoma-associated MG was 71.7{\%}, whereas just 46.2{\%} of 504 patients with non-thymomatous MG underwent follow-up imaging. Abnormal findings were detected in 8.6{\%} of patients with non-thymomatous MG and 26.0{\%} of those with thymoma-associated MG. Abnormal findings included cancer, lung infection and lymph node swelling in the former, and relapse or increased size of thymoma in the latter. Conclusions: Frequent follow up by thoracic imaging is necessary in patients with MG.",
keywords = "cancer, myasthenia gravis, thoracic imaging, thymoma",
author = "Hiroyuki Murai and Yuriko Nagane and Shigeaki Suzuki and Tomihiro Imai and Masakatsu Motomura and Kimiaki Utsugisawa",
year = "2018",
month = "11",
day = "1",
doi = "10.1111/cen3.12481",
language = "English",
volume = "9",
pages = "246--250",
journal = "Clinical and Experimental Neuroimmunology",
issn = "1759-1961",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Significance of follow-up thoracic imaging in myasthenia gravis

AU - Murai, Hiroyuki

AU - Nagane, Yuriko

AU - Suzuki, Shigeaki

AU - Imai, Tomihiro

AU - Motomura, Masakatsu

AU - Utsugisawa, Kimiaki

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Objectives: Most patients with myasthenia gravis (MG) undergo thoracic imaging at initial diagnosis. However, the follow-up protocol is unclear. The objective of the present study was to clarify the follow-up status and main findings of thoracic imaging in patients with MG. Methods: A total of 649 patients with disease duration ≥1 year were included in the study. The follow-up rate and time from the initial scan to the latest thoracic imaging were evaluated. The rate of abnormality and details of abnormal findings in both non-thymomatous MG and thymoma-associated MG were investigated. Results: The follow-up thoracic imaging rate of 145 patients with thymoma-associated MG was 71.7%, whereas just 46.2% of 504 patients with non-thymomatous MG underwent follow-up imaging. Abnormal findings were detected in 8.6% of patients with non-thymomatous MG and 26.0% of those with thymoma-associated MG. Abnormal findings included cancer, lung infection and lymph node swelling in the former, and relapse or increased size of thymoma in the latter. Conclusions: Frequent follow up by thoracic imaging is necessary in patients with MG.

AB - Objectives: Most patients with myasthenia gravis (MG) undergo thoracic imaging at initial diagnosis. However, the follow-up protocol is unclear. The objective of the present study was to clarify the follow-up status and main findings of thoracic imaging in patients with MG. Methods: A total of 649 patients with disease duration ≥1 year were included in the study. The follow-up rate and time from the initial scan to the latest thoracic imaging were evaluated. The rate of abnormality and details of abnormal findings in both non-thymomatous MG and thymoma-associated MG were investigated. Results: The follow-up thoracic imaging rate of 145 patients with thymoma-associated MG was 71.7%, whereas just 46.2% of 504 patients with non-thymomatous MG underwent follow-up imaging. Abnormal findings were detected in 8.6% of patients with non-thymomatous MG and 26.0% of those with thymoma-associated MG. Abnormal findings included cancer, lung infection and lymph node swelling in the former, and relapse or increased size of thymoma in the latter. Conclusions: Frequent follow up by thoracic imaging is necessary in patients with MG.

KW - cancer

KW - myasthenia gravis

KW - thoracic imaging

KW - thymoma

UR - http://www.scopus.com/inward/record.url?scp=85055518388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055518388&partnerID=8YFLogxK

U2 - 10.1111/cen3.12481

DO - 10.1111/cen3.12481

M3 - Article

AN - SCOPUS:85055518388

VL - 9

SP - 246

EP - 250

JO - Clinical and Experimental Neuroimmunology

JF - Clinical and Experimental Neuroimmunology

SN - 1759-1961

IS - 4

ER -